Similarly, the intracellular delivery of anti-ANXA2 antibody inhibited the cellular loss of ProTα-EGFP, resulting in the redistribution of ProTα throughout C6 glioma cells (Figure 3B). Here, ANXA2 is linked to central nervous system cancer.